High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA
- PMID: 32880751
- DOI: 10.1007/s00432-020-03373-w
High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA
Abstract
Purpose: Acute myeloid leukemia (AML) is a heterogenous disease and the survival of AML patients is largely attributed to the improvement of supportive treatment. Wilms' tumor 1-associated protein (WTAP) is a nuclear protein functions in many physiological and pathological processes. Although its expression and function in many malignant diseases have been reported, its prognostic and epigenetic roles in AML are largely unknown.
Methods: Peripheral blood or bone marrow samples were collected from AML patients. The WTAP expression was detected by western blot. WTAP expression level and patients clinical features were analyzed using statistical methods. WTAP knockdown AML cells were constructed. The experiments on proliferation, tumorigenic ability, cell cycle, and apoptosis were performed. Transcriptome sequencing was performed and analyzed. M6A methylation level was measured and m6A-RIP was performed to quantify m6A methylation level of MYC mRNA. RNA stability assay was performed to measure the half-life of mRNA.
Results: WTAP was overexpressed in AML patients and was an independent poor-risk factor in AML (p = 0.0140). Moreover, we found that WTAP regulated proliferation, tumorigenesis, cell cycle, and differentiation of AML cells. Furthermore, WTAP made AML cells resistant to daunorubicin. In further investigations, m6A methylation level was downregulated when knocking down WTAP, and c-Myc was upregulated due to the decreased m6A methylation of MYC mRNA.
Conclusion: High WTAP expression predicts poor prognosis in AML and WTAP plays an epigenetic role in AML.
Keywords: Acute myeloid leukemia; Epigenetics; Wilms’ tumor 1-associated protein; m6A methylation.
Similar articles
-
m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.IUBMB Life. 2021 Jan;73(1):108-117. doi: 10.1002/iub.2410. Epub 2020 Nov 17. IUBMB Life. 2021. PMID: 33205540
-
HIF1α-mediated transactivation of WTAP promotes AML cell proliferation via m6A-dependent stabilization of KDM4B mRNA.Leukemia. 2023 Jun;37(6):1254-1267. doi: 10.1038/s41375-023-01904-1. Epub 2023 Apr 22. Leukemia. 2023. PMID: 37087529
-
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.Mol Cancer. 2019 Aug 22;18(1):127. doi: 10.1186/s12943-019-1053-8. Mol Cancer. 2019. PMID: 31438961 Free PMC article.
-
Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.Biomolecules. 2022 Sep 2;12(9):1224. doi: 10.3390/biom12091224. Biomolecules. 2022. PMID: 36139062 Free PMC article. Review.
-
Deciphering the role of Wnt signaling in acute myeloid leukemia prognosis: how alterations in DNA methylation come into play in patients' prognosis.J Cancer Res Clin Oncol. 2020 Dec;146(12):3097-3109. doi: 10.1007/s00432-020-03407-3. Epub 2020 Sep 27. J Cancer Res Clin Oncol. 2020. PMID: 32980885 Review.
Cited by
-
WTAP and m6A-modified circRNAs modulation during stress response in acute myeloid leukemia progenitor cells.Cell Mol Life Sci. 2024 Jun 23;81(1):276. doi: 10.1007/s00018-024-05299-9. Cell Mol Life Sci. 2024. PMID: 38909325 Free PMC article.
-
WTAP participates in neuronal damage by protein translation of NLRP3 in an m6A-YTHDF1-dependent manner after traumatic brain injury.Int J Surg. 2024 Sep 1;110(9):5396-5408. doi: 10.1097/JS9.0000000000001794. Int J Surg. 2024. PMID: 38874470 Free PMC article.
-
Small molecule inhibitors targeting m6A regulators.J Hematol Oncol. 2024 May 6;17(1):30. doi: 10.1186/s13045-024-01546-5. J Hematol Oncol. 2024. PMID: 38711100 Free PMC article. Review.
-
Regulatory function and mechanism research for m6A modification WTAP via SUCLG2-AS1- miR-17-5p-JAK1 axis in AML.BMC Cancer. 2024 Jan 17;24(1):98. doi: 10.1186/s12885-023-11687-4. BMC Cancer. 2024. PMID: 38233760 Free PMC article.
-
Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.Aging (Albany NY). 2023 Jul 11;15(13):6577-6619. doi: 10.18632/aging.204836. Epub 2023 Jul 11. Aging (Albany NY). 2023. PMID: 37437245 Free PMC article. Review.
References
-
- Bansal H, Yihua Q, Iyer SP, Ganapathy S, Proia DA, Penalva LO, Uren PJ, Suresh U, Carew JS, Karnad AB et al (2014) WTAP is a novel oncogenic protein in acute myeloid leukemia. Leukemia 28:1171–1174 - DOI
-
- Barbolina MV, Adley BP, Shea LD, Stack MS (2008) Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Cancer 112:1632–1641 - DOI
-
- Desrosiers R, Friderici K, Rottman F (1974) Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA 71:3971–3975 - DOI
-
- Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K, Jacob-Hirsch J, Amariglio N, Kupiec M et al (2012) Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485:201–206 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous